InvestorsHub Logo
Followers 85
Posts 5198
Boards Moderated 1
Alias Born 01/23/2010

Re: None

Tuesday, 10/19/2010 6:41:01 PM

Tuesday, October 19, 2010 6:41:01 PM

Post# of 568
Article regarding the medical device market.

US Medical Device Market to Reach $94.9 Billion in 2010
ROCKVILLE, MD--(Marketwire - October 19, 2010) - MarketResearch.com has announced the addition of Espicom Healthcare Intelligence's new report "The Medical Device Market: USA" to their collection of Medical Devices market reports. For more information, visit http://www.marketresearch.com/product/di...

With a population over 300 million, the USA is the third largest country in the world, behind China and India. The largest state is California, with a population of 37 million.

At an estimated US$94.9 billion in 2010, the US medical device market is the world's largest. Per capita expenditure, at US$306, is the third highest in the world.

Much of the market is in private hands; there is no single health system. Public healthcare systems, known as Medicaid, for those on low incomes, are operated by each State. Since 1960, the Medicare system has provided hospital care for the elderly; this has also provided prescription drug coverage since 2006.

President Obama succeeded in signing his healthcare reform bill into law on March 23rd, 2010. The bill, formally called the Patient Protection and Affordable Care Act HR 3590, will eventually extend health insurance cover to an estimated 32 million Americans who don't have any form of health insurance.

The USA is home to many of the world's leading medical device manufacturers, such as Johnson & Johnson, General Electric, Baxter, Covidien and Medtronic. Seven out of the world's top ten device manufacturers are US companies.

Imports are forming an increasingly significant part of the market, and now account for around 31% of the total. This growth is partly explained by US manufacturers using cheap locations abroad, such as Ireland or Mexico, in order to re-export to the US market.

The market is highly regulated, and can be an expensive one in which to operate. It is, however, transparent and 'rules-based.' The US is a major site for R&D and clinical trials.

For more information, visit http://www.marketresearch.com/product/di...